Business Description
OS Therapies Inc
NAICS : 541714
SIC : 2834
ISIN : US68764Y2072
Description
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | -0.36 | |||||
| Debt-to-Equity | -23.62 | |||||
| Debt-to-EBITDA | -3.34 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.07 | |||||
| 9-Day RSI | 65.56 | |||||
| 14-Day RSI | 57.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.76 | |||||
| Quick Ratio | 0.76 | |||||
| Cash Ratio | 0.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -11.63 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -569.57 | |||||
| ROIC % | -32.08 | |||||
| ROC (Joel Greenblatt) % | -69020.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -11.3 | |||||
| EV-to-Forward-EBIT | -9.08 | |||||
| EV-to-EBITDA | -11.3 | |||||
| EV-to-FCF | -9.78 | |||||
| Earnings Yield (Greenblatt) % | -8.85 | |||||
| FCF Yield % | -14.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:OSTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OS Therapies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.403 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 57.31 | ||
| 14-Day ATR ($) | 0.278379 | ||
| 20-Day SMA ($) | 2.087575 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 1.58 - 4.9 | ||
| Shares Outstanding (Mil) | 21.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OS Therapies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OS Therapies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
OS Therapies Inc Frequently Asked Questions
What is OS Therapies Inc(OSTX)'s stock price today?
The current price of OSTX is $2.50. The 52 week high of OSTX is $4.90 and 52 week low is $1.58.
When is next earnings date of OS Therapies Inc(OSTX)?
The next earnings date of OS Therapies Inc(OSTX) is 2025-02-28 Est..
Does OS Therapies Inc(OSTX) pay dividends? If so, how much?
OS Therapies Inc(OSTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers